Chemoinformaics analysis of (z)-Dec-2-en-6,8-diynoic acid isobutylamide
| Molecular Weight | 217.312 | nRot | 5 |
| Heavy Atom Molecular Weight | 198.16 | nRig | 4 |
| Exact Molecular Weight | 217.147 | nRing | 0 |
| Solubility: LogS | -2.97 | nHRing | 0 |
| Solubility: LogP | 3.112 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 37.9511 |
| nHD | 1 | BPOL | 20.4989 |
| QED | 0.554 |
| Synth | 3.341 |
| Natural Product Likeliness | 1.691 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.019 |
| CACO-2 | -3.744 |
| MDCK | 0.00010848 |
| BBB | 0.377 |
| PPB | 0.988315 |
| VDSS | 0.954 |
| FU | 0.017103 |
| CYP1A2-inh | 0.886 |
| CYP1A2-sub | 0.227 |
| CYP2c19-inh | 0.935 |
| CYP2c19-sub | 0.546 |
| CYP2c9-inh | 0.872 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.331 |
| CYP2d6-sub | 0.675 |
| CYP3a4-inh | 0.693 |
| CYP3a4-sub | 0.175 |
| CL | 12.05 |
| T12 | 0.713 |
| hERG | 0.004 |
| Ames | 0.566 |
| ROA | 0.031 |
| SkinSen | 0.949 |
| Carcinogencity | 0.922 |
| EI | 0.923 |
| Respiratory | 0.899 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.55504 |